Industry Analysis Reports | Health Care | Medical Devices

Sunday, 13 December 2020

Dietary Supplements in the Age of Personalized Nutrition Market Trends, Growth, Top Leaders and Demand

Market Overview:

In recent years, the dietary supplement market has witnessed tremendous growth. The major factors influencing the growth of the market include rapid diversification and rising prevalence of various lifestyle diseases worldwide, rising approval from government bodies, growing awareness, and screening for diabetes mellitus, rise in research funding for diagnosis and treatment of these conditions. Furthermore, increasing government healthcare expenditure for the welfare of the population, has spurred the growth of this market. Healthcare expenditure across the globe is continuously increasing. From the last decades, healthcare expenditure in regions like the Americas and Europe has increased. According to the Centers for Medicare & Medicaid Services, in 2015, the U.S. healthcare spending is likely to increase 5.8% reaching USD 3.2 trillion. Since 2016, the healthcare spending in North America has been increased. Canadian healthcare specifically was stressed by an advancing demographic move. Therefore, growing healthcare expenditure.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/5703

Increasing incidence of diseases due to sedentary lifestyle and a lack of balanced diet has majorly influenced the growth of the market. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all global deaths. According to the same study, it was found that 82% of the total deaths occurred in the low and middle-income countries. [FURL=https://www.marketresearchfuture.com/reports/global-dietary-supplements-market-5703/]Dietary supplements in the age of personalized nutrition market[/FURL] plays an important role in the treatment of various lifestyle diseases such as atherosclerosis, cardiovascular disease, stroke; obesity and type 2 diabetes due to which there has been an increasing demand for dietary supplements in the age of personalized nutrition. Changing the dietary approaches and switching to therapeutic lifestyle prove effective in the prevention of hypertension and other cardiovascular disorders. Furthermore, many organizations such as the America Heart Association and the National Heart, Lung and Blood Institute have come up with strategic diets to minimize the risks for cardiovascular and other lifestyle related diseases.

Access Report Details @ https://www.marketresearchfuture.com/reports/global-dietary-supplements-market-5703

Some of the key players in this market are Nestlé Health Science, Danone Nutricia, Carlyle Group, Amway (Nutrilite), Archer Daniels Midland, Abbott Laboratories, Herbalife International, Amway, Danisco, Glanbia, Bayer AG, GlaxoSmithKline plc, Pfizer Inc., Balchem Corporation, Natures Product Inc., Bactolac Pharmaceutical Inc. and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Growth of Ligation Devices Market Size, Share and Regional Forecast till 2024,

Global Ligation Devices Market Report: By Product (Handheld Instruments, Accessories), Procedure (Minimally Invasive Surgery, Open Surgery), and Application (Gastrointestinal and Abdominal, Gynecological, Urological Applications)—Global Forecast till 2024

Market research future will be publishing a Half cooked research report on “Global ligation devices industry trends” that contains the information from 2019 to 2024. Ligation Devices Market is expected to grow at a CAGR 6.7% during the forecast period of 2019 to 2024.

Request Free Sample @ https://www.marketresearchfuture.com/sample_request/7794

Market Research Future (MRFR) recognizes the following companies as the key players in the global Ligation Devices Market that includes Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc.

Market Highlights
Ligation devices are used during surgeries for closing incisions or to join separated organs/tissue parts. Favorable reimbursement policies, rising healthcare expenditure, an increasing number of surgeries, and growing research and development expenditures are the factors driving the market growth. According to the Centers for Disease Control and Prevention in 2017, Coronary heart disease (CHD) was estimated to be the most common type of heart disease within the US and was projected to cause 370,000 per year. However, the high cost of surgery and related side effects are estimated to restraint the market growth.

Segmentation
The global ligation devices market is segmented based on product, procedure, application, end user, and region.

On the basis of product, the market is segmented into handheld instruments and accessories. Based on procedure, the market is segmented into minimally invasive surgery and open surgery. The application segment is segmented into gastrointestinal and abdominal applications, cardiovascular applications, gynecological applications, urological applications, and others. Based on the end user, the market is segmented into hospitals & clinics, ambulatory surgical center, and others.

Regional Analysis

The Americas dominated the global ligation devices market in 2018. Factors such as increasing healthcare expenditure and the rising incidence of chronic diseases are the major drivers within the region.

In 2018, it was estimated that Europe stood second in the global ligation devices market owing to increasing awareness, government support, development of technologically advanced medical products, and a growing number of surgeries. Moreover, the presence of developed economies (Germany, France, UK) boosts the market growth.

Asia-Pacific was the fastest growing region for the global ligation devices market in 2018. Factors such as increasing healthcare infrastructure, favorable government policies, an increasing number of surgeries and rising medical tourism drive the market growth within the region. According to the Indian Brand Equity Foundation in 2017, the Indian healthcare sector was estimated to be one of the fastest growing industries and is estimated to reach USD 280 billion by 2020 with a CAGR of 22.87% from 2015.

On the other hand, the Middle East and Africa held the least share in the global ligation devices market. Factors such as the presence of poor economies and low per capita income, especially within the African region make the market to lag within the region.

Key Players

Some of the key players in the global ligation devices market are Medtronic, Johnson & Johnson, The Cooper Companies, Inc., Conmed Corporation, B. Braun Melsungen AG, Teleflex Incorporated, Olympus Corporation, Applied Medical Resources Corporation, Grena Think Medical, Genicon, Inc., and others.

Covid19 Impact on AI in Drug Discovery Market SWOT Analysis, Major Key Players Revenue, Analysis and Forecasts to 2025

Artificial Intelligence (AI) in Drug Discovery Market Overview

AI drug discovery has proved itself as a vital part of the drugs industry. This technology is used for regulating drug innovation & progress costs and in decreasing the processing time. Fast adoption and other features will help the global AI in the drug discovery market to touch a 41% annual growth rate. AI method uses different algorithms for improving the drug designs, their molecular structures and classification of various forms of drugs. All of the above features are adding to the tally of the market and giving it a considerable push to reach new levels of success.

Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/9393

AI in drug discovery has enlightened the workflow of medical facilities, and on the same page has helped in boosting care facilities. Extensive medical facilities have always tried to opt for better services and latest technologies with minimum space for mistakes. This technology has fastened the drug construction procedures for cases which need specialised medicinal attention, decreases failure risks and also the cost of research & development procedures. All these major features have pushed the authorities to adopt AI technology and have increased the AI in the drug discovery market.

In the absence of AI technology, any new drug development procedures can take years for development and substantial money. Apart from all these factors, AI is still a faraway story for most economies as it is costly, limited awareness and lack of skilled professional workers. These points are a major setback for the growth of the industry.

Artificial Intelligence (AI) in Drug Discovery Market Regional Overview

America, Europe, Asia Pacific and The Middle East & Africa are the four markets observed for the AI in drugs discovery market.

The American region is the current market leader with the US and Canada as the major shareholding markets. Demand for new technologies, the presence of sound AI developers and increased investments in the direction of research & development are the major factors driving the market in this region. This region will maintain its position until the projected period.

The European region is the second-largest AI market. With the increasing demand for faster results and accuracy are helping the global AI in the drug discovery market grow in this region. Authorities and industries are hiring and collaborating with AI experts for easy attainment of such methods.

Asia Pacific region is in third place but will pop out as the fastest growing market in future perspective. There are continuous efforts to make this technology a common practice, and for that, companies are collaborating for better and reliable results.

The Middle East & African region is the smallest industry due to low economic developments and deliberate efforts towards creating a strong medical sector.

Market Segments of the Artificial Intelligence (AI) in Drug Discovery Market

The global market for AI in drug discovery is segmented into three factors:

Product type: There are three types of products, namely software, hardware and services.

Technology-based: Technologies like machine learning, deep learning, natural language processing and querying method are some examples of technology.

Application-based: AI technology is used in candidate screening, preclinical testing, target identification and others.

End-Users: Contract research organisations (CROs), pharma and biotech industries and government research facilities are some of the end-users.

Recent Industry News

As a costly technology, efforts are required to develop more adaptable technologies which become suitable for all and will expand this industries base. Asia Pacific region is making substantial efforts in adopting and developing in technologies, making it the fastest-growing market on a global scale.

Key Players

Microsoft Corporation
IBM Corporation
Google (A Subsidiary of Alphabet Inc.)
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals, Inc.
Insilico Medicine
BenevolentAI
Exscientia
Cyclica
Bioage
Numerate
Numedii, Inc.
Envisagenics
Twoxar, Incorporated
Owkin, Inc.
Xtalpi, Inc.
Verge Genomics
Berg LLC

Read Complete Report With Toc @ https://www.marketresearchfuture.com/reports/ai-drug-discovery-market-9393

Table Of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global AI In Drug Discovery Market, By Product Type

1.1.2. Global AI In Drug Discovery Market, By Molecule Type

1.1.3. Global AI In Drug Discovery Market, By Technology

1.1.4. Global AI In Drug Discovery Market, By Indication

1.1.5. Global AI In Drug Discovery Market, By Application

1.1.6. Global AI In Drug Discovery Market, By End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope Of The Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.2.1. Secondary Research

3.2.2. Primary Research

3.2.2.1. Breakdown Of Primary Respondents

3.2.3. Forecasting Techniques

3.3. Research Methodology For Market Size Estimation

3.3.1. Bottom-Up Approach

3.3.2. Top-Down Approach

3.4. Data Triangulation

3.5. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

Continued...

Healthcare Contract Manufacturing Market- Global Analysis, Regional Trends and Forecast till 2023

Market Scenario

The global healthcare contract manufacturing market is presumed to expand at 9.86 % CAGR during the forecast period (2017-2023) owing to the growing demand for medicine supplies, asserts Market Research Future (MRFR). Healthcare contract manufacturing is the outsourcing of the manufacturing process of drugs to contract manufacturing organizations. It serves other companies in pharmaceutical industries and medical devices to offer comprehensive services from drug development to drug manufacturing.

Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/5637

Drivers and Constraints Impacting the Market

Patent protection expiration of major drugs along with medical devices and competition and economics of trade and production to favor CMO is likely to foster the market growth during the assessment period. The market is likely to expand owing to the growing demand for medical devices and drugs due to the increasing population in the emerging economies. Moreover, with the increasing demand for generic drugs, the rising number of patent expiries, and huge pipeline of drugs, the global market for healthcare contract manufacturing is anticipated to augment in the coming years.

On the flip side, issues of control of third parties coupled with complexities associated with supply chain are considered to retard the market growth over the assessment period. Also, rising complexities in the clinical trials along with lack of in-house laboratory capacity are likely to impede the growth of the market.

Global Healthcare Contract Manufacturing Market: Segmental Analysis

The global healthcare CMO market has been segmented on the basis of service type, type, industry, and region.

By mode of type, the global healthcare contract manufacturing market has been segmented into non-sterile and sterile. Among these, the non-sterile contract manufacturing is estimated to hold the largest market share.

By mode of service type, the global healthcare contract manufacturing market has been segmented into medical device contract manufacturing services and pharmaceutical contract manufacturing services. Among these, the pharmaceutical contract manufacturing services are presumed to hold the largest market share.

By mode of industry, the global healthcare contract manufacturing market has been segmented into biopharmaceutical, medical device, and pharmaceutical. Among these, the segment for medical devices is presumed to hold the largest market share with 43.7 %.

Regional Insights

Geographically, the global healthcare contract manufacturing market span across America, Europe, Asia Pacific, and the Middle East and Africa.

Among all the regions, the American region is anticipated to dominate the global market due to the growing investment in the healthcare sector, focus on research institutions on updating technologies, and presence of strong economic conditions. American contract manufacturers have also upgraded their factories and manufacturing capabilities. With cost-efficient models and advanced manufacturing units, American contract manufacturers are making Asian companies run for their money.

The European region is considered to hold the second position in the global market owing to the presence of high health care spending, and growing support from the government. For instance, according to the Organization for Economic Co-operation and Development, the expenditure on healthcare in Germany in 2014 was EUR 321 billion. France recorded the second highest level with EUR 237 billion.

Asia Pacific is presumed to be the fastest growing market due to the presence of a large number of developing nations in this region, such as China and India. Such developing countries are encouraging the growth of healthcare contract manufacturing market.

Industry News

October 16, 2018: Piramal Enterprises Ltd. is weighing the sale of its contract pharmaceutical business in a potential deal worth $1 billion, citing unidentified people. Piramal Pharma Solutions offer services from drug discovery to development as well as commercial manufacturing, with operations in Europe, North America, and Asia. The company has sent out preliminary marketing materials to potential buyers.

Competitive Dashboard

The major players operating the global market are Boehringer Ingelheim, Benchmark Electronics, Catalant, Patheon, Vetter Pharma International, Hamilton Company, Aesica Pharmaceuticals, AbbVie, Grifols International, Flex Ltd, Lonza Ag, Forefront Medical Technologies, Sanmina Corporation, Evonik Industries, Mylan, S.A, Teva Pharmaceutical Industries, and others.

About Market Research Future:

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Covid19 Impact on Diagnostic imaging Market Size is Expected to Increase at a CAGR 9.1% through 2017 to 2023

Market Highlights

The Global diagnostic imaging market size is projected to grow at a CAGR of 8.2% over the forecast period. In recent years, diagnostic imaging services improved their efficiency and accuracy for the of various acute and chronic diseases including cardiovascular diseases and cancer. The increasing prevalence of geriatric population and subsequent growth in the incidence of cardiac, and neurological diseases including cancer, growing government funding’s for development of medical diagnostics field, and the on-going technological advancements in imaging services are some factors that are anticipated to drive the market growth during the assessment period. Additionally, increasing demand for diagnostic imaging devices and development expenditure by the government as well as private sector is likely to contribute to the market growth. As per the data by the Office for National Statistics, in 2016, the gross domestic expenditure on research and development (R&D) was Euro 33.1 billion (USD 35.2 billion) in the UK. However, high cost of diagnostic imaging devices and unfavorable reimbursement policies may hamper the market growth during the assessment period.

Get Latest Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/7186

Segmentation

The Global diagnostic imaging services market has been segmented into procedure, application, and service provider.

By procedure, the market has been segmented into X-ray, Computed Tomography, Ultrasound, MRI (Magnetic Resonance Imaging), Nuclear Imaging, Radiography and others. The procedure segment is estimated to hold major market share in the global diagnostic imaging services market due to the rising R&D activities in the medical diagnostics field.

On the basis of application, the global diagnostic imaging services market has been segmented into Neurology, Cardiology, Oncology, Musculoskeletal and others.

The Global diagnostic imaging services market, by service provider, has been segmented into Clinics & Hospitals, Diagnostic centers, Research laboratories and others.

Key Players

Some of the prominent players in the global diagnostic imaging services market are Center for Diagnostic Imaging (CDI), Medquest Associates Inc./Novant Health, Simonmed/Dignity Health, Touchstone Imaging, Alliance Medical, Medica Group, Sonic Healthcare, Global Diagnostics, Consensys Imaging Service, Inc., Progressive Radiology, Concord Medical Services Holdings Limited, Alliance Healthcare Services, InHealth Group and others.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/diagnostic-imaging-services-market-7186

Regional Analysis

On regional basis, the Americas is anticipated to dominate the global diagnostic imaging services market owing to the growing clinical R&D budgets by both government as well as public and private organizations in diagnostic imaging modalities and increasing adoption of advanced technologies in the region. Additionally, rising prevalence of geriatric population along with various chronic diseases is contributing the growth of this market. According to a report by Population Reference Bureau, the number of older population (aged 65 and above) will rise to nearly 24% from 15% by 2060. Europe is expected to hold the second largest position in the global diagnostic imaging services market owing to the presence of strong academic & research base and availability of funding for research in the European countries. Moreover, rising healthcare expenditure and awareness among people for detection of diseases is boosting the market in this region. The Asia-Pacific region is anticipated to be fastest growing region is due to rising demand for imaging devices, good quality healthcare infrastructure and incidence of major key players for growth and development in this region. The Middle East & Africa has the least share of the global diagnostic imaging services market. Moreover, the major market share of the region is expected to be held by the Middle East region owing to the increasing government initiatives for the healthcare sector.

Table Of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Detection Technique Trends & Assessment

Chapter 5. Market Factor Analysis

Continued....

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Technology Trends on Lower GI Series Market Size, Share and Global Demand

Market Insights

Market Research Future presents a comprehensive study on the global lower GI series market, stating that the market is going to expand until the year 2023 at a CAGR of 4.6%. This global report sums up by providing the development of lower GI series market and involves driving the factors that boost the market.

A lower GI series is referred to as lower gastrointestinal series or barium enema, which is one of the medical procedures used in the examination and diagnosis of problems related to the human colon or large intestine and rectum. This test also helps in detecting diseases and abnormalities as the symptoms of the problem generated. Due to such importance of lower GI series, many companies are on the verge of investing a significant amount in research & development to introduce more of such efficient method. This factor is taking the global lower GI series market towards positive growth in the years to come, as per the research reports stated.

Global Lower GI Series Market: Drivers & Trends

The global lower GI series market analysis has seen prospective growth in recent days. Earlier, the diagnosis of diseases in the human colon, large intestine, and rectum was very complex and challenging to diagnose. However, with the invention of a lower GI series test has pushed the healthcare industry to the next level of advancements. Therefore, the factors such as technological advancements, growing disposable income, raising people awareness about the lower GI series test has put a potential scope for the global lower GI series market to expand exponentially and would gain more valuation during the forecast period. The increase in the number of healthcare centers, hospitals, clinics, and laboratories in main regional segments, globally have also driven the global lower GI series market.

On the other hand, the global lower GI series market is also driven majorly owing to the factors such as surging incidence of GI diseases, gastric cancer, and most prominent is changing lifestyle. With that, more factors such as developing technologies, increasing cost-effective methods, and the government’s support for research have also boosted the growth of the global lower GI series market.

On the flip side, some factors such as the availability of alternative therapies are marked to be one of the reasons that could hamper the growth of the market during the assessment period.

Key Players

Here is the list of key players in this market:

Eisai (US)
Cadila Pharmaceuticals
PeaceHealth
Purdue Pharma L.P.
Alfa Wassermann
NOVADAQ
Mount Sinai Beth Israel
AstraZeneca
Ironwood Pharmaceuticals Inc.

Market Segmentation

This MRFR report segments the global lower GI series market into applications, types of tests, and end user.

By the mode of applications, the market has been segmented into gastroenteritis, colon polyps, tumor, strictures crohn's disease, ulcerative colitis, and others.

By the mode of types of test, the market is segmented into double-contrast test and single-contrast test.

By the mode of end users, this market is segmented into hospitals, clinics, and laboratories.

Regional Outlook

Geographically, the global lower GI series market research study segments the global lower GI series market into the regions of America, Europe, Asia Pacific, and the Middle East & Africa.

Among all, the reports tell that America holds a significant share in the global lower GI series market, owing to the enormous investment that is being made in research and development in the healthcare sector as well as its stable economic conditions for research and development. With this, the mounting patient base and geriatric population are also there to boost the growth of the market.

Whereas, Europe is the second largest market after the Asia Pacific on account of increasing technological improvements. The technological enhancements will thereby, result in higher efficiency and accuracy for the diagnosis process.

Moreover, Asia Pacific has recorded to be the fastest growing market owing to the swelling prevalence of contagious diseases in this region. India and China have now started investing in research and development of the healthcare sector, which is expected to boost the global lower GI series market in this region.

About Market Research Future:

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Covid19 Impact on Aromatherapy Market 2018-2023 – Global Trends, Statistics, Size, Share, Regional Analysis by Key Players, Application & Products

Aromatherapy is an alternative form of medicine which relies on scented oils and other essential compounds for improving the well-being of individuals. It can be used in conjunction with other complementary treatments of acupuncture or massage for management of chronic diseases or other medical symptoms. The global aromatherapy market report compiled by Market Research Future (MRFR) contains drivers, trends, developments, and challenges new entrants and existing players can face in the period of 2017 to 2023.

Get Latest Free Sample PDF of COVID-19/CoronaVirus Impact Analysis of Aromatherapy Market 2020@ https://www.marketresearchfuture.com/sample_request/3241

Market Overview

As per MRFR, the global aromatherapy market analysis is poised to display a CAGR of 6.18% from 2017 to 2023 (forecast period). It can touch a value of USD 4.3 billion by 2023. Benefits of the treatment after inhalation of the aroma can induce relaxation is likely to bode well for the market. A prime example includes the diffusion of eucalyptus oil can assist in digestion of foods.

Changes in lifestyles of consumers and a large number of people opting for the complementary treatment are other major drivers of the market. Clinical trials advocating the advantages of aromatherapy for the treatment of disorders can influence the market considerably. According to Cancer.gov, 58 patients showed a decrease in depression and anxiety after completion of aromatherapy sessions. Availability of various oils at lifestyle stores and online channels can fuel the global aromatherapy market growth till 2023.

But lack of proper regulations and allergic reaction of the oil to customers are factors which can prevent market growth.

Segmentation

The global aromatherapy market is segmented by product, application, and therapeutic application.

By product, it is segmented into essential oils, carrier oils & blended oils, equipment, and others. Essential oils are further segmented into herbaceous/camphoraceous, green/vegetative, spicy, citrus, floral, and others. Ultrasonic diffuser, heat diffuser, and nebulizer diffuser are other segments subsumed within the equipment segment.

By application, it is segmented into aerial diffusion, inhalation, and tropical.

By therapeutic application, it is segmented into skin and hair care, relaxation and sleep, pain management, and others.

Regional Analysis

Asia Pacific (APAC), North America, Europe, and the Middle East & Africa (MEA) are the regions discussed with respect to the market report.

North America is estimated to be one of the profitable regions for the global aromatherapy market till 2023 due to consumers opting for the treatment in the U.S. The large population and their high expendable income levels are major growth drivers of the region.

Europe is the second-largest region with France and Italy proving to be the revenue generators. Pursuance of healthy lifestyles as well as renewed interest among the people residing in the region are prime factors driving market growth. The inclusion of essential oils by popular cosmetic brands can boost the global aromatherapy market demand.

The APAC region can display a robust CAGR during the forecast period driven by consumer demand in China and India. Rising number of accidents combined with the use of oils for treating burns and scars as natural remedies can bode well for the market. Furthermore, old traditions and rituals in addition to the large number of tourists visiting for experiences can bode well for the region.

Lastly, the MEA region can contribute to the market due to the regions of Saudi Arabia and UAE. Efforts by respective governments for promoting tourism can be a viable factor for the expansion of the global aromatherapy market in the region.

Competition Outlook

Muji, Nu Skin, Tree of Life, Neal's Yard Remedies, NOW Foods, Young Living, Air Aroma, doTERRA, and Zija International are notable industry participants of the global aromatherapy market. Launch of new products and associated stationery are being launched by players for promoting the alternative form of treatment.

Industry News

Aromafloria, the US based producer of bath and body products, has launched aromatherapy based products in its new product line of Cannafloria Essentials. It contains cannabis terpenes which gives the solutions a distinct aroma.

About Market Research Future:

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Industry Analysis Reports | Health Care | Medical Devices | Pharmaceutical

Labels

Sunday, 13 December 2020

Dietary Supplements in the Age of Personalized Nutrition Market Trends, Growth, Top Leaders and Demand

Growth of Ligation Devices Market Size, Share and Regional Forecast till 2024,

Covid19 Impact on AI in Drug Discovery Market SWOT Analysis, Major Key Players Revenue, Analysis and Forecasts to 2025

Healthcare Contract Manufacturing Market- Global Analysis, Regional Trends and Forecast till 2023

Covid19 Impact on Diagnostic imaging Market Size is Expected to Increase at a CAGR 9.1% through 2017 to 2023

Technology Trends on Lower GI Series Market Size, Share and Global Demand

Covid19 Impact on Aromatherapy Market 2018-2023 – Global Trends, Statistics, Size, Share, Regional Analysis by Key Players, Application & Products

Blog Archive

Total Pageviews